tiprankstipranks
Trending News
More News >
COSCIENS Biopharma (TSE:CSCI)
TSX:CSCI
US Market

COSCIENS Biopharma (CSCI) Income Statement

Compare
40 Followers

COSCIENS Biopharma Income Statement

Last quarter (Q2 2024), COSCIENS Biopharma's total revenue was $2.34M, an increase of 4.05% from the same quarter last year. In Q2, COSCIENS Biopharma's net income was $-1.42M. See COSCIENS Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.50M$ 5.64M$ 5.26M$ 3.65M$ 532.00K
Gross Profit
$ 4.28M$ 5.48M$ 5.17M$ 1.33M$ 122.00K
Operating Expenses
$ 22.28M$ 20.74M$ 13.84M$ 7.40M$ 9.67M
Depreciation and Amortization
$ 16.00K$ 16.00K$ 145.00K$ 232.00K$ 315.00K
EBITDA
$ -17.99M$ -15.36M$ 2.85M$ -5.69M$ -9.23M
Operating Income
$ -18.01M$ -15.38M$ -8.67M$ -5.92M$ -9.54M
Other Income/Expenses
$ 1.46M$ -7.35M$ 194.00K$ 1.20M$ 3.48M
Pretax Income
$ -16.55M$ -22.73M$ -8.48M$ -4.72M$ -6.23M
Net Income
$ -3.55M$ 3.24M$ 2.64M$ 1.46M$ -6.04M
Per Share Metrics
Basic EPS
$ -1.92$ 1.87$ 1.33$ 0.66$ -8.75
Diluted EPS
$ -1.92$ 1.87$ 1.33$ 0.66$ -8.63
Weighted Average Shares Outstanding
4.86M 4.86M 4.60M 1.64M 690.51K
Weighted Average Shares Outstanding (Diluted)
4.86M 4.86M 4.60M 1.64M 699.78K
Currency in USD

COSCIENS Biopharma Earnings and Revenue History